Medicinal – Page 93

Functionalized Micellar Membranes from Medicinal Mushrooms as Promising Self-Growing Bioscaffolds

mycolabadmin

Scientists created special membranes from medicinal mushrooms that can help heal wounds and regenerate damaged skin. These membranes are grown naturally in liquid culture and enriched with extract from mango peels to fight bacteria and promote healing. The material is completely natural, biodegradable, and performs better than many conventional wound healing materials, making it an eco-friendly option for medical applications.

Diversity and functions of fungal VOCs with special reference to the multiple bioactivities of the mushroom alcohol

mycolabadmin

Fungi release various volatile compounds (VOCs) that have different effects on organisms and the environment. The most notable fungal VOC is 1-octen-3-ol, also called mushroom alcohol, which gives mushrooms their distinctive smell. This compound can inhibit fungal growth, repel insects, and help control plant diseases, but at high concentrations it may be toxic to humans and trigger immune responses. Scientists use fruit flies as a model to study how these fungal compounds affect health.

Morpho-phylogenetic evidence reveals novel hyphomycetous fungi on medicinal plants in Southwestern China

mycolabadmin

Researchers in China discovered 12 new species of fungi living on medicinal plants, along with several previously unreported fungal occurrences. These fungi were identified using both microscopic examination and DNA analysis. Some of these fungi can produce harmful toxins, while others produce beneficial compounds that affect medicinal plant quality. This research helps us better understand the invisible fungal world living on the plants we use for medicine.

The First Whole Genome Sequence and Methylation Profile of Gerronema lapidescens QL01

mycolabadmin

Scientists have sequenced the complete genome of Lei Wan (Gerronema lapidescens), a medicinal mushroom used in traditional Chinese medicine for treating parasitic infections and digestive problems. The research reveals the mushroom’s genetic blueprint, including genes responsible for producing beneficial compounds and adapting to rocky mountain environments. This foundational work aims to enable sustainable cultivation of this rare fungus and development of new medicinal treatments, addressing current conservation threats from over-harvesting.

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Researchers studied three dangerous fungi that cause serious infections called mucormycosis. They examined the outer coating of these fungi, called the cell wall, which is made of sugar-like molecules called polysaccharides. When these fungi were exposed to human immune cells, they triggered strong inflammatory responses. Understanding these fungal components could help develop better treatments and vaccines for this life-threatening infection.

Identification of fungal agents isolated from burn lesions using mycological and molecular methods in patients admitted to Velayat burn hospital in Rasht city during 2022–2023

mycolabadmin

Researchers studied fungal infections in burn patients at a hospital in Iran and found that non-albicans Candida fungi, particularly a species called Candida parapsilosis, were the most common culprits. Using laboratory cultures and genetic testing, they identified 101 fungal infections out of 380 burn patients. Understanding which fungi cause these infections is important for doctors to choose the right treatment and improve patient outcomes.

Neonatal Invasive Candidiasis: Current Concepts

mycolabadmin

Neonatal invasive candidiasis is a serious fungal infection affecting premature and very low birth weight babies. The types of fungi causing these infections are changing globally, with more resistant strains appearing, especially in lower-income countries. Treatment options are limited by this resistance, making prevention through hygiene and proper hospital practices increasingly important.

Caspofungin therapy in prosthetic valve endocarditis and candidemia due to itraconazole-resistant Candida glabrata (Nakaseomyces glabratus): A case report

mycolabadmin

A 13-year-old boy developed a serious fungal infection on his replacement heart valve after recent surgery. The fungal infection was caused by a type of yeast called Candida glabrata that was resistant to the initial antifungal medication. After testing revealed resistance and biofilm formation, doctors switched to caspofungin, a stronger antifungal drug, and the patient recovered successfully.

Kinome analysis of Madurella mycetomatis identified kinases in the cell wall integrity pathway as novel potential therapeutic drug targets in eumycetoma caused by Madurella mycetomatis

mycolabadmin

Eumycetoma is a serious fungal infection that causes large tumors under the skin and is very difficult to treat. Scientists used computer analysis to find special proteins called kinases in the fungus that might be good targets for new drugs. They discovered that proteins involved in the fungus’s cell wall are promising targets, which could lead to better treatments for this neglected disease.

Leveraging synthetic genetic array screening to identify therapeutic targets and inhibitors for combatting azole resistance in Candida glabrata

mycolabadmin

Candida glabrata is a dangerous fungus causing serious infections that is becoming resistant to antifungal drugs. Researchers used a genetic screening technique to find genes that interact with drug resistance mutations and identified methotrexate (a drug already used for arthritis) as a potential partner for fluconazole treatment. When combined, these drugs work better together against resistant strains of the fungus, offering hope for treating these stubborn infections.

Research Topic: Medicinal